| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of ONCOTELIC THERAPEUTCS INC by Oncotelic Therapeutics, Inc. (OTCQB:OTLC) through any online brokerage.
There are no as such competitors for ONCOTELIC THERAPEUTCS INC by Oncotelic Therapeutics, Inc..
There is no analysis for ONCOTELIC THERAPEUTCS INC by Oncotelic Therapeutics, Inc. to provide a consensus price target.
The stock price for ONCOTELIC THERAPEUTCS INC by Oncotelic Therapeutics, Inc. (OTCQB: OTLC) is $0.0166 last updated October 16, 2026 at 3:56 PM EDT.
There are no upcoming dividends for ONCOTELIC THERAPEUTCS INC by Oncotelic Therapeutics, Inc..
ONCOTELIC THERAPEUTCS INC by Oncotelic Therapeutics, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for ONCOTELIC THERAPEUTCS INC by Oncotelic Therapeutics, Inc..
ONCOTELIC THERAPEUTCS INC by Oncotelic Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.
Oncotelic Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing drugs for the treatment of orphan oncology indications, developing antisense and small molecule injectable drugs for the treatment of cancer. OT-101 is...